Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Sulforaphane sensitizes human breast cancer cells to paclitaxel-induced apoptosis by downregulating the NF-κB signaling pathway.

Kim SH, Park HJ, Moon DO.

Oncol Lett. 2017 Jun;13(6):4427-4432. doi: 10.3892/ol.2017.5950. Epub 2017 Mar 29.

2.

Growth inhibition of human breast carcinoma cells by overexpression of regulator of G-protein signaling 4.

Park HJ, Kim SH, Moon DO.

Oncol Lett. 2017 Jun;13(6):4357-4363. doi: 10.3892/ol.2017.6009. Epub 2017 Apr 7.

3.

Lifetime Risk of Symptomatic Hand Osteoarthritis: The Johnston County Osteoarthritis Project.

Qin J, Barbour KE, Murphy LB, Nelson AE, Schwartz TA, Helmick CG, Allen KD, Renner JB, Baker NA, Jordan JM.

Arthritis Rheumatol. 2017 Jun;69(6):1204-1212. doi: 10.1002/art.40097. Epub 2017 May 8.

PMID:
28470947
4.

How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling.

Onisko A, Druzdzel MJ, Austin RM.

J Pathol Inform. 2016 Dec 30;7:50. doi: 10.4103/2153-3539.197191. eCollection 2016.

5.

Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC Study (Atherosclerosis Risk in Communities).

Tang W, Yao L, Roetker NS, Alonso A, Lutsey PL, Steenson CC, Lederle FA, Hunter DW, Bengtson LG, Guan W, Missov E, Folsom AR.

Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2468-2477. Epub 2016 Nov 10.

PMID:
27834688
6.

Lifetime risk of diabetes among First Nations and non-First Nations people.

Turin TC, Saad N, Jun M, Tonelli M, Ma Z, Barnabe CC, Manns B, Hemmelgarn B.

CMAJ. 2016 Nov 1;188(16):1147-1153. Epub 2016 Sep 19.

7.

Risk of ESRD in the United States.

Albertus P, Morgenstern H, Robinson B, Saran R.

Am J Kidney Dis. 2016 Dec;68(6):862-872. doi: 10.1053/j.ajkd.2016.05.030. Epub 2016 Aug 28.

PMID:
27578184
8.

High DRC Levels Are Associated with Let-7b Overexpression in Women with Breast Cancer.

Encarnación J, Ortiz C, Vergne R, Vargas W, Coppola D, Matta JL.

Int J Mol Sci. 2016 Jun 2;17(6). pii: E865. doi: 10.3390/ijms17060865.

9.

Lifetime Risk of Venous Thromboembolism in Two Cohort Studies.

Bell EJ, Lutsey PL, Basu S, Cushman M, Heckbert SR, Lloyd-Jones DM, Folsom AR.

Am J Med. 2016 Mar;129(3):339.e19-26. doi: 10.1016/j.amjmed.2015.10.014. Epub 2015 Nov 18.

10.
11.

Rapid automatic segmentation of abnormal tissue in late gadolinium enhancement cardiovascular magnetic resonance images for improved management of long-standing persistent atrial fibrillation.

Giannakidis A, Nyktari E, Keegan J, Pierce I, Suman Horduna I, Haldar S, Pennell DJ, Mohiaddin R, Wong T, Firmin DN.

Biomed Eng Online. 2015 Oct 7;14:88. doi: 10.1186/s12938-015-0083-8.

12.

Genome-wide analysis of microRNA and mRNA expression signatures in cancer.

Li MH, Fu SB, Xiao HS.

Acta Pharmacol Sin. 2015 Oct;36(10):1200-11. doi: 10.1038/aps.2015.67. Epub 2015 Aug 24. Review.

13.

Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960.

Ahmad AS, Ormiston-Smith N, Sasieni PD.

Br J Cancer. 2015 Mar 3;112(5):943-7. doi: 10.1038/bjc.2014.606. Epub 2015 Feb 3.

14.

Identification of valid reference genes for the normalization of RT-qPCR expression studies in human breast cancer cell lines treated with and without transient transfection.

Liu LL, Zhao H, Ma TF, Ge F, Chen CS, Zhang YP.

PLoS One. 2015 Jan 24;10(1):e0117058. doi: 10.1371/journal.pone.0117058. eCollection 2015.

15.

Vacuum-assisted breast biopsy for breast cancer.

Park HL, Hong J.

Gland Surg. 2014 May;3(2):120-7. doi: 10.3978/j.issn.2227-684X.2014.02.03. Review.

16.

Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection.

Li CC, Chi JL, Ma Y, Li JH, Xia CQ, Li L, Chen Z, Chen XL.

Radiat Oncol. 2014 Jun 23;9:144. doi: 10.1186/1748-717X-9-144.

17.

Novel Phenotypic Fluorescent Three-Dimensional Co-Culture Platforms for Recapitulating Tumor in vivo Progression and for Personalized Therapy.

Fang C, Man YG, Cuttitta F, Stetler-Stevenson W, Salomon D, Mazar A, Kulesza P, Rosen S, Avital I, Stojadinovic A, Jewett A, Jiang B, Mulshine J.

J Cancer. 2013 Dec 1;4(9):755-63. doi: 10.7150/jca.7813. eCollection 2013.

18.

Captious certainties: makings, meanings and misreadings of consumer-oriented genetic testing.

Paul NW, Banerjee M, Michl S.

J Community Genet. 2014 Jan;5(1):81-7. doi: 10.1007/s12687-013-0172-y. Epub 2013 Nov 8.

19.
20.

Tissue biomarkers of breast cancer and their association with conventional pathologic features.

Chung L, Shibli S, Moore K, Elder EE, Boyle FM, Marsh DJ, Baxter RC.

Br J Cancer. 2013 Feb 5;108(2):351-60. doi: 10.1038/bjc.2012.552. Epub 2013 Jan 8.

Supplemental Content

Support Center